<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10835757</identifier>
<setSpec>0034-9887</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Alvarez, M</dc:author>
<dc:author>Riquelme, F</dc:author>
<dc:author>Glasinovic, J C</dc:author>
<dc:author>Soza, A</dc:author>
<dc:author>Arrese, M</dc:author>
<dc:author>Duarte, I</dc:author>
<dc:description xml:lang="en">We report a 72 years old diabetic male that, after the use of combined amoxicillin-clavulanic acid, developed pruritus and jaundice. Liver function tests showed serum total bilirubin of 4.3 mg/dL aspartate aminotransferase 140 U/l (normal &lt; 35 U/L), alanine aminotransferase 470 U/L (normal &lt; 40) and alkaline phosphatases of 400 U/L (normal &lt; 100). Serology for hepatitis A, B and C viruses was negative, ERCP showed a normal biliary tree and liver biopsy disclosed a cholestatic hepatitis. Ursodeoxycholic was started to relieve pruritus. Liver function tests improved shortly thereafter, suggesting that this drug may be useful in the treatment of drug induced cholestasis.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>1999 Dec </dc:date>
<dc:title xml:lang="es">Hepatotoxicidad por amoxicilina/ácido clavulánico: caso clínico.</dc:title>
<dc:title xml:lang="en">[Hepatotoxicity by amoxicillin/clavulanic acid: case report].</dc:title>
<dc:publisher>Revista medica de Chile</dc:publisher>
</metadata>
</record>
</pubmed-document>
